SIGNIFICANT IMPROVEMENT IN MELANOMA SURVIVAL OVER THE LAST DECADE: A HUNGARIAN NATIONWIDE STUDY BETWEEN 2011–2019
Gabriella Liszkay, Angela Benedek, Csaba Polgár, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Zoltán Polányi, Kata Knollmajer, Máté Várnai, Zoltán Vokó, Balázs Nagy, György Rokszin, Ibolya Fábián, Zsófia Barcza, Rolland Gyulai, Zoltan Kiss
doi: https://doi.org/10.1101/2022.04.06.22273390
Gabriella Liszkay
1National Institute of Oncology, Budapest, Hungary
Angela Benedek
2MSD Pharma Hungary Ltd., Budapest, Hungary
Csaba Polgár
1National Institute of Oncology, Budapest, Hungary
Judit Oláh
4Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary
Péter Holló
5Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary
Gabriella Emri
6Department of Dermatology, University of Debrecen, Debrecen, Hungary
András Csejtei
7Department of Oncoradiology, Markusovszky University Teaching Hospital, Szombathely, Hungary
István Kenessey
1National Institute of Oncology, Budapest, Hungary
Zoltán Polányi
2MSD Pharma Hungary Ltd., Budapest, Hungary
Kata Knollmajer
2MSD Pharma Hungary Ltd., Budapest, Hungary
Máté Várnai
2MSD Pharma Hungary Ltd., Budapest, Hungary
3Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary
Zoltán Vokó
3Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary
Balázs Nagy
3Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary
György Rokszin
8RxTarget Ltd., Szolnok, Hungary
Ibolya Fábián
8RxTarget Ltd., Szolnok, Hungary
9University of Veterinary Medicine, Budapest, Hungary
Zsófia Barcza
10Syntesia Medical Communications Ltd., Budapest, Hungary
Rolland Gyulai
11Department of Dermatology, Venereology and Oncodermatology, Faculty of Medicine, University of Pécs, Pécs, Hungary
Zoltan Kiss
2MSD Pharma Hungary Ltd., Budapest, Hungary

Data Availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Posted April 12, 2022.
SIGNIFICANT IMPROVEMENT IN MELANOMA SURVIVAL OVER THE LAST DECADE: A HUNGARIAN NATIONWIDE STUDY BETWEEN 2011–2019
Gabriella Liszkay, Angela Benedek, Csaba Polgár, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Zoltán Polányi, Kata Knollmajer, Máté Várnai, Zoltán Vokó, Balázs Nagy, György Rokszin, Ibolya Fábián, Zsófia Barcza, Rolland Gyulai, Zoltan Kiss
medRxiv 2022.04.06.22273390; doi: https://doi.org/10.1101/2022.04.06.22273390
SIGNIFICANT IMPROVEMENT IN MELANOMA SURVIVAL OVER THE LAST DECADE: A HUNGARIAN NATIONWIDE STUDY BETWEEN 2011–2019
Gabriella Liszkay, Angela Benedek, Csaba Polgár, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Zoltán Polányi, Kata Knollmajer, Máté Várnai, Zoltán Vokó, Balázs Nagy, György Rokszin, Ibolya Fábián, Zsófia Barcza, Rolland Gyulai, Zoltan Kiss
medRxiv 2022.04.06.22273390; doi: https://doi.org/10.1101/2022.04.06.22273390
Subject Area
Subject Areas
- Addiction Medicine (243)
- Allergy and Immunology (525)
- Anesthesia (125)
- Cardiovascular Medicine (1434)
- Dermatology (158)
- Emergency Medicine (292)
- Epidemiology (10333)
- Gastroenterology (533)
- Genetic and Genomic Medicine (2653)
- Geriatric Medicine (255)
- Health Economics (499)
- Health Informatics (1744)
- Health Policy (791)
- Hematology (269)
- HIV/AIDS (571)
- Medical Education (276)
- Medical Ethics (83)
- Nephrology (291)
- Neurology (2483)
- Nursing (145)
- Nutrition (381)
- Oncology (1335)
- Ophthalmology (403)
- Orthopedics (152)
- Otolaryngology (239)
- Pain Medicine (172)
- Palliative Medicine (51)
- Pathology (345)
- Pediatrics (786)
- Primary Care Research (297)
- Public and Global Health (5031)
- Radiology and Imaging (902)
- Respiratory Medicine (688)
- Rheumatology (309)
- Sports Medicine (246)
- Surgery (300)
- Toxicology (45)
- Transplantation (141)
- Urology (108)